Tools

LEADER 07007cam a2200769 i 4500

001 ssj0002114870;

003 WaSeSS;

005 20230512140707.0;

006 m d ;

007 cr n ;

008 220222s2018 enka sb 001 0 eng d;

010 a| 2021277744;

015 a| GBB8B94722| bnb;

016 7 a| 1017351482| DNLM;

016 7 a| 0189212472| Uk;

020 a| 9780128144237q| hardcover;

020 a| 0128144238q| hardcover;

020 z| 9780128144244 (ePub ebook);

035 a| (WaSeSS)ssj0002114870;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| RS200b| .D66 2018;

060 00 a| 2018 H-478;

060 10 a| QV 786;

245 00 a| Dosage form design considerations.n| Volume Ih| [electronic resource] /c| edited by Rakesh K. Tekade.;

260 a| London, United Kingdom ;a| San Diego, CA, United States :b| Academic Press/Elsevier,c| [2018];

300 a| xvii, 861 pages :b| illustrations ;c| 25 cm.;

490 1 a| Advances in pharmaceutical product development and research series;

500 a| 1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS.;

504 a| Includes bibliographical references and index.;

505 1 a| 1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

650 0 a| Drugsx| Dosage forms.=| ^A800954;

650 0 a| Drugsx| Design.=| ^A477567;

650 0 a| Drug development.=| ^A443888;

650 0 a| Drug delivery systems.=| ^A297949;

650 12 a| Dosage Forms=| ^A918881;

650 22 a| Drug Compounding=| ^A920260;

650 22 a| Drug Design=| ^A925973;

650 2 a| Drug Delivery Systems=| ^A927384;

650 6 a| Médicamentsx| Formes pharmaceutiques.;

650 6 a| Médicamentsx| Conception.;

650 6 a| Médicamentsx| Développement.;

650 6 a| Systèmes d'administration de médicaments.;

650 7 a| Drug delivery systems.2| fast0| (OCoLC)fst00898667;

650 7 a| Drug development.2| fast0| (OCoLC)fst00898670;

650 7 a| Drugsx| Design.2| fast0| (OCoLC)fst00898790;

650 7 a| Drugsx| Dosage forms.2| fast0| (OCoLC)fst00898801;

650 7 a| Formes pharmaceutiques.2| ram0| (FrPBN)11962013;

650 7 a| Médicamentsx| Mise au point.2| ram0| (FrPBN)13177938;

650 7 a| Médicamentsx| Composition chimique.2| ram0| (FrPBN)12500373;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Tekade, Rakesh K.?| UNAUTHORIZED;

776 08 i| ebook version :z| 9780128144244;

830 0 a| Advances in pharmaceutical product development and research series.?| UNAUTHORIZED;

856 40 z| Full text available from eBook - Pharmacology, Toxicology and Pharmaceutical Science 2018u| https://go.openathens.net/redirector/ecu.edu?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Fbook%2F9780128144237;

947 a| (OCoLC)on1049562445;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5860820;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5860820-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 7/17/2022x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5860820-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 7/17/2022x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5860820-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 7/17/2022x| EBOOKz| JERESOURCE;

Dosage form design considerations. / edited by Rakesh K. Tekade.

Other author	Tekade, Rakesh K.
Format	Electronic
Publication Info	London, United Kingdom ; San Diego, CA, United States : Academic Press/Elsevier, [2018]
Description	xvii, 861 pages : illustrations ; 25 cm.
Supplemental Content	Full text available from eBook - Pharmacology, Toxicology and Pharmaceutical Science 2018
Subjects	Drugs--Dosage forms. Drugs--Design. Drug development. Drug delivery systems. Dosage Forms Drug Compounding Drug Design Drug Delivery Systems Médicaments--Formes pharmaceutiques. Médicaments--Conception. Médicaments--Développement. Systèmes d'administration de médicaments.

Series	Advances in pharmaceutical product development and research series Advances in pharmaceutical product development and research series. UNAUTHORIZED
Incomplete content	1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS
General note	1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Issued in other form	ebook version : 9780128144244
Genre/form	Electronic books.
LCCN	2021277744
ISBN	9780128144237 hardcover
ISBN	0128144238 hardcover

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Dosage form design considerations. / edited by Rakesh K. Tekade.

Click here for more information about this title

Availability